Globus Medical Profile



Odds of Distress

Analyze Filter    Fiscal Quarter End: December 31, 2019
Equity ratings for Globus Medical are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 9, 2019 and ending today December 8, 2019. Click here to learn more.

Globus Medical Profile

Next fiscal quarter end is expected on December 31, 2019. Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 1800 people. more
Globus Medical Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
Globus Medical SEC Filings
Globus Medical SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameGlobus Medical
ChairmanDavid PaulView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 4 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Medical Devices
InstrumentUSA Stock View All
RegionNorth America
LocationPennsylvania; U.S.A
Business Address2560 General Armistead Avenue
ExchangeBATS Exchange
CIK Number0001237831
IndustryMedical Devices
Phone610 930 1800
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestNovember 15, 2019
Globus Medical (GMED) is traded on BATS Exchange in USA. It is located in 2560 General Armistead Avenue and employs 1,800 people. Globus Medical is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with current market capitalization of 5.14 B. Globus Medical conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 76.65 M outstanding shares of which 1.23 M shares are currently shorted by private and institutional investors with about 2.32 trading days to cover. Globus Medical currently holds about 240.43 M in cash with 32.12 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.43.
Check Globus Medical Probability Of Bankruptcy

Ownership Allocation (%)

Globus Medical Target Price Odds Analysis

Odds Below 57.18HorizonTargetOdds Above 57.18
97.55%30 days 57.18 2.41%
Based on normal probability distribution, the odds of Globus Medical to move above current price in 30 days from now is roughly 2.41 (This Globus Medical probability density function shows the probability of Globus Medical Stock to fall within a particular range of prices over 30 days) .

Globus Medical Top Holders

Globus Medical Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Globus Medical Key Fundamentals

Globus Medical Against Markets

Did you try this?

Run Theme Ratings Now


Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Globus Medical Upcoming and Recent Events

Globus Medical Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 20, 2020
Next Earnings ReportMay 7, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 20, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Globus Medical Corporate Filings

Globus Medical SEC Reporting

Financial Statements and Exhibits. Results of Operations and Financial Condition
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Unclassified Corporate Event
Other Events

Globus Medical Corporate Directors

Steve Zarrilli Director
Ann Rhoads Independent Director
Robert Liptak Independent Director
Please also check Risk vs Return Analysis. Please also try CEO Directory module to screen ceos from public companies around the world.